about
Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.Allele-Specific Quantitative PCR for Accurate, Rapid, and Cost-Effective Genotyping.Correction of Monogenic and Common Retinal Disorders with Gene Therapy.CRISPR Editing in Biological and Biomedical Investigation.Zebrafish as a Model for the Study of Chaperonopathies.RNA-Guided CRISPR-Cas9 System-Mediated Engineering of Acute Myeloid Leukemia Mutations.The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal modelsThe present and future of genome editing in cancer research.CRISPR and the Rebirth of Synthetic Biology.Somatic Engineering of Oncogenic Chromosomal Rearrangements: A PerspectiveTherapeutic applications of CRISPR RNA-guided genome editing.Gene and cell-based therapies for inherited retinal disorders: An update.Lesch-Nyhan Syndrome: Models, Theories, and Therapies.Cell and small animal models for phenotypic drug discovery.The Conserved Sonic Hedgehog Limb Enhancer Consists of Discrete Functional Elements that Regulate Precise Spatial ExpressionUnraveling Macrophage Heterogeneity in Erythroblastic IslandsA convenient method to pre-screen candidate guide RNAs for CRISPR/Cas9 gene editing by NHEJ-mediated integration of a 'self-cleaving' GFP-expression plasmid.The Conspicuity of CRISPR-Cpf1 System as a Significant Breakthrough in Genome Editing.Safety and Efficacy of AAV Retrograde Pancreatic Ductal Gene Delivery in Normal and Pancreatic Cancer Mice.Strategies to advance drug discovery in rare monogenic intellectual disability syndromes.CRISPR in the Retina: Evaluation of Future Potential.The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.Using the Zebrafish as an Approach to Examine the Mechanisms of Vertebrate Erythropoiesis.In Vivo Applications of CRISPR-Based Genome Editing in the Retina.Genetics and biology of prostate cancerLight-activated cell identification and sorting (LACIS) for selection of edited clones on a nanofluidic deviceHemochorial placentation: development, function, and adaptationsBlossom of CRISPR technologies and applications in disease treatment
P2860
Q33899971-6A7EA7D2-236F-4B49-9DD0-1A1CEBC46AC2Q37061245-16A97A0E-19C4-499E-B51B-D81BFF2EFF73Q37676230-87863BCE-E84C-46D2-8E20-9CBD49122E77Q38645581-4712095F-A73A-4CEE-9F77-49A8743E919BQ38712393-B83CF4A7-B8B8-4E23-A52C-20E51E2D3C72Q38742015-9200CB97-3FD4-4626-8145-CA055FB474C1Q38836751-11D7FEE0-661D-4DA0-87B5-ED6737271B02Q38840267-684D46BA-6621-4FEC-8C75-2D27194C2EA9Q38871483-97ED880F-B8EF-4765-B84C-F4A8BE9C2B36Q38926441-C964605B-2F8C-40ED-ABF6-06C7BBE54A20Q38937607-21722F73-1817-4573-A328-DFC9928EF244Q39013159-F563C3E6-84AF-4192-BFE1-B0AC72AB8C8BQ39030151-D8CC8105-0590-42B1-8AC8-81FB8D09D948Q39442815-9AB776AB-A7FD-47B0-984A-2FC6989510D9Q41447969-D4ECAC3D-1A5C-4FF0-9BF0-C16793C9F119Q42010457-FC324671-CCBF-4A77-B9F5-05B064740574Q46340316-F20050DC-42AC-4422-ABFA-6BB442358046Q47299533-0FE117A9-D57E-48A1-B615-E269E44A03AAQ47551580-3FF34794-F875-400D-9385-10CE500DDBCAQ47595271-6C594EAE-C1EF-410F-8B3E-B98AE7F5251EQ47843961-BD837913-4EC6-4283-82B1-E83610B5EC4DQ49432567-94B89BF3-E55A-4A2B-A87C-B8BE6E528198Q50093953-C959A6F9-AFCF-4B29-AB2C-09C6B182291EQ55262727-675122E4-B762-4086-97BC-6AD477CFBB6FQ57106917-1AB5D37D-57E8-4D38-AFF1-52D00EE28E92Q57145480-9D2CCA42-9932-4D2C-A7F8-13A556A49239Q57177754-BC4A1CE7-A023-4E25-B526-C3EB0AADF2D3Q58120494-15AD3C81-9773-425D-8447-1D76FDC0519E
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Modeling Disease In Vivo With CRISPR/Cas9.
@en
type
label
Modeling Disease In Vivo With CRISPR/Cas9.
@en
prefLabel
Modeling Disease In Vivo With CRISPR/Cas9.
@en
P2860
P1476
Modeling Disease In Vivo With CRISPR/Cas9.
@en
P2093
Lukas E Dow
P2860
P304
P356
10.1016/J.MOLMED.2015.07.006
P577
2015-10-01T00:00:00Z